Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer
Pratt, Brenda E, Hindorf, Cecilia, Chittenden, Sarah J, Parker, Christopher C, Flux, Glenn D
Published in Nuclear medicine communications (01.02.2018)
Published in Nuclear medicine communications (01.02.2018)
Get more information
Journal Article
A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer
Flux, Glenn D., Haq, Masud, Chittenden, Sarah J., Buckley, Susan, Hindorf, Cecilia, Newbold, Kate, Harmer, Clive L.
Published in European journal of nuclear medicine and molecular imaging (01.02.2010)
Published in European journal of nuclear medicine and molecular imaging (01.02.2010)
Get full text
Journal Article
Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
Published in European journal of nuclear medicine and molecular imaging (01.04.2017)
Published in European journal of nuclear medicine and molecular imaging (01.04.2017)
Get full text
Journal Article
Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer
Taprogge, Jan, Murray, Iain, Gear, Jonathan, Chittenden, Sarah J., Parker, Christopher C., Flux, Glenn D.
Published in International journal of radiation oncology, biology, physics (15.11.2019)
Published in International journal of radiation oncology, biology, physics (15.11.2019)
Get full text
Journal Article
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
Denis-Bacelar, Ana M, Chittenden, Sarah J, McCready, V Ralph, Divoli, Antigoni, Dearnaley, David P, O'Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
Published in British journal of radiology (01.04.2018)
Published in British journal of radiology (01.04.2018)
Get full text
Journal Article
A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases
Denis-Bacelar, Ana M, Chittenden, Sarah J, Murray, Iain, Divoli, Antigoni, Ralph McCready, V, Dearnaley, David P, O'Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
Published in Physics in medicine & biology (07.04.2017)
Published in Physics in medicine & biology (07.04.2017)
Get full text
Journal Article
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
Murray, Iain, Chittenden, Sarah J., Denis-Bacelar, Ana M., Hindorf, Cecilia, Parker, Christopher C., Chua, Sue, Flux, Glenn D.
Published in European journal of nuclear medicine and molecular imaging (01.10.2017)
Published in European journal of nuclear medicine and molecular imaging (01.10.2017)
Get full text
Journal Article
Reply to ‘Single high dose versus repeated bone-targeted radionuclide therapy’
Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
Published in European journal of nuclear medicine and molecular imaging (01.03.2018)
Published in European journal of nuclear medicine and molecular imaging (01.03.2018)
Get full text
Journal Article
InfuShield: a shielded enclosure for administering therapeutic radioisotope treatments using standard syringe pumps
Rushforth, Dominic P, Pratt, Brenda E, Chittenden, Sarah J, Murray, Iain S, Causer, Louise, Grey, Matthew J, Gear, Jonathan I, Du, Yong, Flux, Glenn D
Published in Nuclear medicine communications (01.03.2017)
Published in Nuclear medicine communications (01.03.2017)
Get more information
Journal Article
Reply to: Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation?
Flux, Glenn D., Haq, Masud, Chittenden, Sarah J., Buckley, Susan, Hindorf, Cecilia, Newbold, Kate, Harmer, Clive L.
Published in European journal of nuclear medicine and molecular imaging (01.05.2010)
Published in European journal of nuclear medicine and molecular imaging (01.05.2010)
Get full text
Journal Article
Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapy
Chittenden, Sarah J, Pratt, Brenda E, Pomeroy, Kay, Black, Peter, Long, Clive, Smith, Nicholas, Buckley, Susan E, Saran, Frank H, Flux, Glenn D
Published in Cancer biotherapy & radiopharmaceuticals (01.04.2007)
Published in Cancer biotherapy & radiopharmaceuticals (01.04.2007)
Get full text
Journal Article
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of Ra-223-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Chittenden, Sarah J., Hindorf, Cecilia, Parker, Christopher C., Lewington, Valerie J., Pratt, Brenda E., Johnson, Bernadette, Flux, Glenn D.
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Get full text
Journal Article
The potential of ^sup 223^Ra and ^sup 18^F-fluoride imaging to predict bone lesion response to treatment with ^sup 223^Ra-dichloride in castration-resistant prostate cancer
Murray, Iain, Chittenden, Sarah J, Denis-bacelar, Ana M, Hindorf, Cecilia, Parker, Christopher C, Chua, Sue, Flux, Glenn D
Published in European journal of nuclear medicine and molecular imaging (01.10.2017)
Published in European journal of nuclear medicine and molecular imaging (01.10.2017)
Get full text
Journal Article
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223 Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Chittenden, Sarah J., Hindorf, Cecilia, Parker, Christopher C., Lewington, Valerie J., Pratt, Brenda E., Johnson, Bernadette, Flux, Glenn D.
Published in Journal of Nuclear Medicine (01.09.2015)
Published in Journal of Nuclear Medicine (01.09.2015)
Get full text
Journal Article
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of ^sup 223^Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Chittenden, Sarah J, Hindorf, Cecilia, Parker, Christopher C, Lewington, Valerie J, Pratt, Brenda E, Johnson, Bernadette, Flux, Glenn D
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Get full text
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Journal Article
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of sigma up 223 nu a-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Chittenden, Sarah J, Hindorf, Cecilia, Parker, Christopher C, Lewington, Valerie J, Pratt, Brenda E, Johnson, Bernadette, Flux, Glenn D
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Get full text
Published in The Journal of nuclear medicine (1978) (01.09.2015)
Journal Article
Phase I/II trials of super(186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival
Denis-Bacelar, Ana M, Chittenden, Sarah J, Dearnaley, David P, Divoli, Antigoni, O'Sullivan, Joe M, McCready, VRalph, Johnson, Bernadette, Du, Yong, Flux, Glenn D
Published in European journal of nuclear medicine and molecular imaging (01.04.2017)
Published in European journal of nuclear medicine and molecular imaging (01.04.2017)
Get full text
Journal Article